Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2025-12-24 @ 6:55 PM
NCT ID:
NCT02491957
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with stage 0-III breast cancer within the past 3 years
* Must have completed local therapy for their breast cancer
* Must have received systemic therapy for their breast cancer (anti-estrogen and/or chemotherapy)
* Chemotherapy must be complete prior to entry
* Anti-estrogen therapy may be ongoing
* Ambulatory without assistive devices
* No orthopedic restrictions or neurologic deficits that would limit ability to complete the Power Protocol (based on the opinion of the investigator)
* No requirement for supplemental O2
* No unstable angina, regular use of nitroglycerin for exertional angina, or MI within the last 12 months
* No local or distant recurrence of their breast cancer
* No active lymphedema
* No history of hemorrhagic stroke
* No Heparin or Coumadin Use
* No symptomatic peripheral vascular obstructions
* No active gallbladder disease
* No active kidney stones
* No active gout
* No active diverticulitis
* No pituitary diseases or growth
* Able to provide written informed consent and authorization for release of health information
* Able to commit to LOFT training 2 times/week for 4 weeks
Exclusion Criteria:
* Inability to meet one of the inclusion criteria above.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02491957
Study Brief:
Protocol Section:
NCT02491957